Generics 19

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Trimebutine manufacturers

19 products found

Filters

19 products found

trimebutine

Capsules 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16171
Since the 1900s, a European pharmaceutical firm has been there for health professionals and health organizations, sharing healthcare and patient quality of life via a culture built on passion, integrity, and transparency. The Company's most noticeable values are its people-oriented policy, which applies to all customers and collaborators, as well as its constant and attentive attention to national and worldwide markets.

Manufacturer usually replies in 5 days

trimebutine

Tablets 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #1178
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe and CIS for 20+ years. Key production lines are Rx, nutraceuticals, and dermo-cosmetics. The company's production lines are GMP-compliant. Main dosage forms include solid oral, suppositories, creams, and gels.

Manufacturer usually replies in 6 days

trimebutine

Tablets 100 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #10033
A pharmaceutical manufacturer based in Europe specializes in development and manufacturing for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. The main therapy areas include the immune system, CNS, and cardiovascular system. The main dosage forms include solid oral and injectable.

Manufacturer usually replies in 11 days

trimebutine

Oral suspension 24 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP
Manufacturer #10281
It is part of the pharmaceutical and medicine manufacturing industry and is located in Europe. The company's purpose is to be on the lookout for new ways to improve human health and quality of life. Respect for the individual, openness to progress, reasonable power, and respect for the work, workplace, and community are the company's principles.

Manufacturer usually replies in 5 days

trimebutine

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18778
The company concentrates on product display and optimum profits in this segment. It could include practitioners’ and pharmacists’ insight into a brand/product, about Over the Counter medicines (OTC). The company is focused on continuous engagement with clients and in-depth understanding translates into the right customized solutions.

Manufacturer usually replies in 2 days

trimebutine

Tablets 200 mg , 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Registered in
Argentina
Available for
Licensing with supply, Distribution only
Manufacturer #15733
One of the leading manufacturers in cosmetic and medicinal products in the South American Continent. The company has been committed since 1990-is to developing and manufacturing high-quality products that allow healing and improve someone’s life. They are a major exporter of its therapies to different regions such as Latin America and Asia. Medicine is manufactured for pain, gastroenterology, hepatology, and cardiology.

Manufacturer usually replies in 8 days

trimebutine + diazepam

Tablets, film coated 100 mg + 3.5 mg, 100 mg + 3.5 mg, 200 mg + 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17925
The company’s goal is to exceed its accomplishments to improve the quality of living, as well as the hope and well-being of millions of people. The company’s dedication to quality has allowed it to achieve prestige and significant market share. The core focus of the company is the development, production, and marketing of pharmaceutical products designed to help healthcare providers improve healthcare delivery.

Manufacturer usually replies in 7 days

trimebutine + simethicone

Tablets 200 mg + 120 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17925
The company’s goal is to exceed its accomplishments to improve the quality of living, as well as the hope and well-being of millions of people. The company’s dedication to quality has allowed it to achieve prestige and significant market share. The core focus of the company is the development, production, and marketing of pharmaceutical products designed to help healthcare providers improve healthcare delivery.

Manufacturer usually replies in 7 days

trimebutine

Tablets, prolonged release (PR) 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17925
The company’s goal is to exceed its accomplishments to improve the quality of living, as well as the hope and well-being of millions of people. The company’s dedication to quality has allowed it to achieve prestige and significant market share. The core focus of the company is the development, production, and marketing of pharmaceutical products designed to help healthcare providers improve healthcare delivery.

Manufacturer usually replies in 7 days

trimebutine

Tablets 100 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17925
The company’s goal is to exceed its accomplishments to improve the quality of living, as well as the hope and well-being of millions of people. The company’s dedication to quality has allowed it to achieve prestige and significant market share. The core focus of the company is the development, production, and marketing of pharmaceutical products designed to help healthcare providers improve healthcare delivery.

Manufacturer usually replies in 7 days

trimebutine + simethicone

Tablets 200 mg + 120 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17885
The company was established in the initial of 1930s. The company’s mission is to develop and elaborate medicinal specialties of high quality and efficacy to offer trustworthy therapeutic alternatives to health professionals; in short, to offer the national and international medical community, medicines of excellence and quality

Manufacturer usually replies in 10 days

trimebutine + simethicone

Tablets, film coated 200mg + 120mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Available for
Distribution only
Manufacturer #16240
It is a laboratory that produces several product lines, such as allergy, cardiology, clinic, dermatology, gastroenterology, geriatrics, neurology, pediatrics, psychiatry, and urology, among others.

Manufacturer usually replies in 6 days

trimebutine + bromazepam

Tablets 100mg + 1.5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16189
A pharmaceutical leader that deals with the development, manufacturing, and commercializing of pharmaceutical specialties, medicines as well as drugs to improve patient health and condition. The goal is to offer the utmost medical attention that goes with time and keeps the service delivery optimum.

Manufacturer usually replies in 7 days

trimebutine + simethicone

Tablets, film coated 200mg + 120mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16189
A pharmaceutical leader that deals with the development, manufacturing, and commercializing of pharmaceutical specialties, medicines as well as drugs to improve patient health and condition. The goal is to offer the utmost medical attention that goes with time and keeps the service delivery optimum.

Manufacturer usually replies in 7 days

trimebutine

Tablets, prolonged release (PR) 300mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16189
A pharmaceutical leader that deals with the development, manufacturing, and commercializing of pharmaceutical specialties, medicines as well as drugs to improve patient health and condition. The goal is to offer the utmost medical attention that goes with time and keeps the service delivery optimum.

Manufacturer usually replies in 7 days

trimebutine

Tablets 100mg, 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16189
A pharmaceutical leader that deals with the development, manufacturing, and commercializing of pharmaceutical specialties, medicines as well as drugs to improve patient health and condition. The goal is to offer the utmost medical attention that goes with time and keeps the service delivery optimum.

Manufacturer usually replies in 7 days

trimebutine

Tablets 100 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
PICS
Manufacturer #446
It was established in the late 1950s with one ideology of respect for life and customer first. One of the major achievements of the company is in the field of ophthalmic disease. All products are GMP certified. The manufacturer sells more than 150 prescription medicine which includes the circulatory and digestive system, as well as antibiotics. It is an international company that delivers pharmaceutical products to domestic and international markets in China, ASEAN countries, the Middle East, Africa, and more.

Manufacturer usually replies in 9 days

trimebutine

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19820

Manufacturer usually replies in 11 days

trimebutine

Capsules 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #463

Manufacturer usually replies in 11 days

Trimebutine:

Trimebutine is a medication used for the treatment of irritable bowel syndrome and other gastrointestinal disorders. It is for sale in various forms and sold under global brand names such as Debridat, Recutin, Polybutin, Trimedad, and Modulon. It was originally discovered by a pharmaceutical products manufacturing company and subsequently gained approval for use in many countries across the world, such as Canada and several others. However, it is notably not available in the United States as it has not been FDA approved. Currently, it has proved popular in the global marketplace with it being listed for sale by many trimebutine manufacturers and trimebutine suppliers. Where it is subsequently listed on the wholesale pharmaceutical products list of global distributors, at a variety of cost and price points.

Mechanism of action of Trimebutine:

Trimebutine belongs to a group of drugs termed spasmolytic agents. These serve to regulate both intestinal and colonic motility and are able to relieve abdominal pain through antimuscarinic and weak mu opioid agonist effects. At sufficiently elevated concentrations, trimebutine inhibits extracellular calcium ion influx in the smooth muscle cells through voltage-dependent L-type calcium ion channels and further calcium ion release from intracellular calcium ion stores. It does this by binding to the inactivated state of the calcium channel with high affinity, reducing calcium influx, which attenuates membrane depolarization and decreases colon peristalsis. It also serves to modulate potassium ion release and concentrations, furthering its clinical properties.

Form and dosage of Trimebutine:

The final form and packaging are dependent on the manufacturers and suppliers, as well as the specific distributors and order. However, trimebutine typically is for sale in forms including tablets, capsules, film-coated tablets, and modified-release tablets. In the treatment of gastrointestinal problems, the adult recommended dose consists of up to 600 mg daily taken in 3 divided doses (200 mg 3 times daily) before meals. Many things can affect the dose of a medication that a person needs, such as body weight, other medical conditions, and other medications. Therefore, it is important to follow the recommendation of the prescribing medical official and to review the manufacturers’ literature.

Trimebutine on Pipelinepharma:

Currently, at the time of writing, we have found 21 verified trimebutine manufacturers and trimebutine suppliers from our online global list of B2B sellers. These manufacturers, suppliers, and distributors are located in various countries including the European Union, Turkey, Argentina, and South Korea. Each company and their pharmaceutical products list listed on our online B2B platform has been verified by the Pipelinepharma team. This ensures seller reputability while reducing souring mileage and dead ends, allowing for a hassle-free buying experience.

Price of Trimebutine and how to buy:

As with other pharmaceutical products listed on the Pipelinepharma marketplace, the specific wholesale cost of trimebutine remains negotiable online between both B2B parties through the Pipelinepharma interface, or through a trusted system of your choice. This allows for flexibility and ease of negotiability. However, if desired the manufacturer or supplier may choose to include the desired cost for their product, facilitating trade and providing a baseline for further negotiation. If this is indicated, an ‘Accept’ and ‘Negotiate’ button will be shown, with a ‘Get offer’ button being displayed in the absence of a listed price.